canada semaglutide patent Ozempic's problem: how Novo Nordisk lost control of a blockbuster drug. 💉 Demand for GLP-1 weight-loss drugs has exploded, turning Ozempic into a $40bn+ revenue engine for Novo Nordisk. But, despite Hims and Hers (NYSE: HIMS)

Exploring oxidative modifications of tyrosine: an update on mechanisms of formation, advances in analysis and biological consequences

In the human body, L-carnitine is used to transport fatty acids into the cell's power plants (mitochondria), where they are "burned" into energy

However, the fluids nutrients, minerals, and medicines can stay in your body for days, weeks, or even months

The anti-obesity medication (AOM) marketplace is rapidly expanding, with analysts estimating it to be worth $150 billion by 2032, fueled by the increasing demand for effective weight management (e.g., 15-25% weight loss) and metabolic health solutions